About Dinutuximab Beta
Class: | Monoclonal antibody (anti-GD2 antibody)
Use: | Treatment of high-risk neuroblastoma in pediatric patients, particularly for patients who have achieved at least a partial response to prior therapy
Adult dose: | Not established; primarily used in pediatric populations
Pediatric dose: | 17.5 mg/m² administered as an intravenous infusion over 10 hours, given once daily for 5 consecutive days every 28 days for up to 5 cycles
Side effects: | Common side effects include pain, fever, hy
Drug Class
Monoclonal antibody (anti-GD2 antibody)
Uses & Indications
Treatment of high-risk neuroblastoma in pediatric patients, particularly for patients who have achieved at least a partial response to prior therapy
Storage Requirements
Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Manufacturer & Packaging
Manufacturer: RECORDATI RARE DISEASES[PUTEAUX;France], France
Package Size
1 Glass Vial (4.5 mL)
Price & Supplier
Price in UAE: AED 47530.00
Dosage Information
Adult Dose
Not established; primarily used in pediatric populations
Pediatric Dose
17.5 mg/m² administered as an intravenous infusion over 10 hours, given once daily for 5 consecutive days every 28 days for up to 5 cycles
Side Effects
Common side effects include pain, fever, hypotension, allergic reactions, and infusion-related reactions
Contraindications & Precautions
Hypersensitivity to dinutuximab beta or any component of the formulation; caution in patients with a history of severe allergic reactions
Important Warnings
Risk of severe infusion reactions; monitor patients closely during and after infusion; may cause neurotoxicity; ensure adequate hydration and pain management prior to administration
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.